(Q40177549)

18 September 2017

1 reference

title

Diagnosis and treatment of cystic fibrosis. An update (English)

1 reference

18 September 2017

0 references

P B Davis

1

1 reference

PubMed ID

6373170

18 September 2017

P A di Sant'Agnese

series ordinal

2

1 reference

PubMed ID

6373170

18 September 2017

language of work or name

English

0 references

publication date

1 June 1984

1 reference

18 September 2017

1 reference

18 September 2017

85

1 reference

18 September 2017

6

1 reference

18 September 2017

802-809

1 reference

Research in cystic fibrosis (first of three parts)

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Low sweat electrolytes in a patient with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Report of the committe for a study for evaluation of testing for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Aminoglycoside clearance in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Antibiotic Management in Patients with Chronic Bronchitis and Emphysema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Long-term treatment of bronchlectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

The Ketchup-Bottle Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Cystic fibrosis: physical exercise versus chest physiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Bronchial artery embolization in cystic fibrosis; technique and long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Effectiveness of cimetidine as an adjunct to supplemental pancreatic enzymes in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Chloride impermeability in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

Cystic fibrosis and pregnancy. A national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0012-3692%2816%2962421-2

10.1016/S0012-3692(16)62421-2

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

6373170